Status:
COMPLETED
A Continuous Glucose Monitor Based Insulin Bolus Calculator (CGM-IBC) Study B
Lead Sponsor:
Welldoc
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor.
Detailed Description
Individuals with type 1 diabetes and those with type 2 diabetes who are prescribed bolus insulin must decide on an insulin dose for any given meal. This dose is often based on what they are eating and...
Eligibility Criteria
Inclusion
- Type 1 or type 2 diabetes using the Dexcom G6 continuous glucose monitor
Exclusion
- Pregnancy
Key Trial Info
Start Date :
July 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2022
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05343065
Start Date
July 5 2022
End Date
December 20 2022
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MedStar Health Research Institute
Baltimore, Maryland, United States, 21239